Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9182082 | 0.75 | TSHR (0.30) | — | |
| SCHEMBL3825569 | 0.75 | TSHR (0.30) | — | |
| SCHEMBL11202722 | 0.73 | IDO1 (0.38) | — | |
| SCHEMBL7451655 | 0.72 | MGLL (0.39) | MEN1KMT2ATDP1 | |
| SCHEMBL9181769 | 0.72 | LMNA (0.36) | — | |
| SCHEMBL9185329 | 0.72 | AKR1B1 (0.41) | MEN1KMT2ATDP1 | |
| SCHEMBL3825796 | 0.71 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL9180692 | 0.68 | CYP1A2 (0.33) | — | |
| SCHEMBL7454500 | 0.66 | ALDH1A1 (0.32) | KCNN4 | |
| SCHEMBL8808259 | 0.66 | NR1H2 (0.31) | KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036064-A4 | SELECTIVE BETA 3-ADRENERGIC AGONISTS | LILLY CO ELI (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1036064-A1 | SELECTIVE BETA 3-ADRENERGIC AGONISTS | ELI LILLY AND COMPANY (US) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029672-A1 | SELECTIVE β3 ADRENERGIC AGONISTS | ELI LILLY AND COMPANY (US) | 1999-06-17 | — | — | WO | disclosed |
| WO-1999029673-A1 | SELECTIVE β3 ADRENERGIC AGONISTS | ELI LILLY AND COMPANY (US) | 1999-06-17 | — | — | WO | disclosed |